Antibodies are under appreciated in the current pandemic. They are protective in 20-30 minutes after being administered. They benefit people who are currently ill and they last 6-8 weeks. In contrast, while vaccines are critically important, they do not benefit people who are currently ill.
Spike Protein Neutralizing Antibody
This human monoclonal antibody targets the SARS-CoV-2 spike protein and could have dual purpose for potential use in neutralizing the virus and for detection in diagnostic applications.
Anti-ACE2 Blocking Antibody
This human monoclonal antibody targets ACE2 receptor, which is the target cellular receptor for coronavirus infection.
We have four DNA and RNA vaccines under review.